| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/01/2013 | US20130195845 Anti-erbb2 antibodies |
| 08/01/2013 | US20130195844 Antibodies against human il17 and uses thereof |
| 08/01/2013 | US20130195843 Biomarkers for Non-Hodgkin Lymphomas and Uses Thereof |
| 08/01/2013 | US20130195832 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases |
| 08/01/2013 | US20130195763 Methods and compositions for improving sleep and memory |
| 08/01/2013 | US20130195761 Compositions comprising anti-cap37 antibodies and methods of production and use thereof |
| 08/01/2013 | US20130195756 99mTc IMAGING AGENTS AND METHODS OF USE |
| 08/01/2013 | CA2857967A1 Composition and method for the diagnosis and treatment of diseases associated with neurite degeneration |
| 07/31/2013 | EP2620452A1 Binding members for IGE molecules |
| 07/31/2013 | EP2620451A1 Methods for inhibiting the binding of endosialin to ligands |
| 07/31/2013 | EP2620450A2 Anti-CTLA-4 antibody compositions |
| 07/31/2013 | EP2620449A1 Anti-ephrin-b2 antibody and use thereof |
| 07/31/2013 | EP2620448A1 Anti-hepcidin antibodies and methods of use |
| 07/31/2013 | EP2619589A1 Assay for a type ii collagen biomarker |
| 07/31/2013 | EP2619581A2 Immunochromatography devices, methods and kits |
| 07/31/2013 | EP2619312A1 Oncolytic adenoviral vectors coding for monoclonal anti - ctla - 4 antibodies |
| 07/31/2013 | EP2619228A1 Therapeutic factor viii antibodies |
| 07/31/2013 | EP2619227A1 Super-humanized antibodies |
| 07/31/2013 | EP2619226A2 Carrier immunoglobulins and uses thereof |
| 07/31/2013 | EP2618904A1 Purification of antibodies using simulated moving bed chromatography |
| 07/31/2013 | EP2618843A2 Novel hiv-1 broadly neutralizing antibodies |
| 07/31/2013 | EP2618833A2 Breast cancer therapeutics |
| 07/31/2013 | EP1476185B1 Antibodies to cd40 |
| 07/31/2013 | CN103228675A Compositions, antibodies, asthma diagnosis methods, and methods for preparing antibodies |
| 07/31/2013 | CN103228674A Methods and compositions for neural disease immunotherapy |
| 07/31/2013 | CN103228673A Anti-human trop- antibody having antitumor activity in vivo |
| 07/31/2013 | CN103228130A Animal models and therapeutic molecules |
| 07/31/2013 | CN103224912A Monoclonal antibody of anti-Cyfip protein, and application thereof |
| 07/31/2013 | CN103224562A Epitope regions of a thyrotrophin (TSH) receptor, and antibodies thereto |
| 07/31/2013 | CN103224561A Staphylococcal enterotoxin micromolecule antibody and its preparation method and use |
| 07/31/2013 | CN103224560A Staphylococcal enterotoxin gene engineering reshaped antibody and its preparation method and use |
| 07/31/2013 | CN103224559A Human HIV broad spectrum neutralization antibody A16, associated biological material and applications thereof |
| 07/31/2013 | CN103224448A Hapten, artificial antigen and antibody of pentabrominated diphenyl ethers-121 |
| 07/31/2013 | CN102659926B Pc-E polypeptide inhibiting aspergillus fumigatus from adhering to cornea |
| 07/31/2013 | CN102584949B Pc-C polypeptide inhibiting aspergillus fumigatus from adhering to cornea |
| 07/31/2013 | CN102336814B Polypeptide sequence for preparing anti-liver-neoplasm marker CK-19 antibody, polyclonal antibody and application thereof |
| 07/31/2013 | CN102250240B Method for purifying human immunoglobulin from separated component I+III of blood plasma |
| 07/31/2013 | CN101949925B Colloidal gold chromatographic test strip for rapidly testing prednisone acetate and derivative thereof and preparation method |
| 07/31/2013 | CN101668853B Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them |
| 07/31/2013 | CN101498728B Reagent kit for detecting o-allyl phenol and its special antibody |
| 07/31/2013 | CN101379192B Anti-Met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products |
| 07/31/2013 | CN101124247B Antibodies directed against amyloid-beta peptide and uses thereof |
| 07/30/2013 | US8497358 Antibody purification method |
| 07/30/2013 | US8497355 Anti-glypican-3 antibody having improved kinetics in plasma |
| 07/30/2013 | US8497354 Antibodies to endoplasmin and their use |
| 07/30/2013 | US8497351 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer |
| 07/30/2013 | US8497246 Using blood brain barrier receptor specific immunoglobullin as diagnostic and therapeutic for prevention, detection treatment of brain disorders |
| 07/30/2013 | US8497244 Methods for targeting pulmonary diseases with agents that bind a target in pulmonary tissue |
| 07/30/2013 | US8497118 Chimeric immunoreceptor useful in treating human cancers |
| 07/30/2013 | US8497093 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 07/30/2013 | US8497072 Amyloid-beta globulomer antibodies |
| 07/30/2013 | US8496933 VHNAR anti-cytokine domains |
| 07/30/2013 | US8496930 Method of stabilizing antibody and stabilized solution-type antibody preparation |
| 07/30/2013 | US8496929 Generating antibodies; cardiovascular disorders |
| 07/30/2013 | CA2704083C Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 07/30/2013 | CA2582113C A method of antibody purification |
| 07/30/2013 | CA2540138C Recombinant antibody against human insulin-like growth factor |
| 07/30/2013 | CA2534639C Anti-cd19 antibodies |
| 07/30/2013 | CA2521490C Production of recombinant igm in per.c6 cells |
| 07/30/2013 | CA2518944C Inhibitors of extracellular hsp90 |
| 07/30/2013 | CA2502668C Fully human antibody fab fragments with human interferon-gamma neutralizing activity |
| 07/30/2013 | CA2499816C Optimized fc variants and methods for their generation |
| 07/30/2013 | CA2442010C New elongase gene and production of.delta. 9-polyunsaturated fatty acids |
| 07/30/2013 | CA2425174C Human gene critical to fertility |
| 07/25/2013 | WO2013110069A1 Glutamic acid-stabilized insulin analogues |
| 07/25/2013 | WO2013109974A2 Anti-cxcr3 antibodies |
| 07/25/2013 | WO2013109856A2 Methods of using fgf19 modulators |
| 07/25/2013 | WO2013109829A1 Anti-adamts4 antibodies and methods of treatment |
| 07/25/2013 | WO2013109185A1 Novel antibodies |
| 07/25/2013 | WO2013108561A1 Marker peptide for determining risk of developing metabolic syndrome and use thereof |
| 07/25/2013 | WO2013107791A1 Targeted mutant alpha-helical bundle cytokines |
| 07/25/2013 | WO2013107290A1 A novel paramyxovirus and uses thereof |
| 07/25/2013 | WO2013086260A3 Combination therapy for treatment of cancer |
| 07/25/2013 | WO2013076702A3 Monoclonal antibodies specific for the m2-1 antigen of respiratory syncytial virus (rsv) |
| 07/25/2013 | WO2013072523A4 Bi-specific antibodies for medical use |
| 07/25/2013 | WO2013071016A3 Methods of inhibiting tumor growth by antagonizing il-6 receptor |
| 07/25/2013 | WO2013068946A3 Antibodies specific for trop-2 and their uses |
| 07/25/2013 | WO2013043070A3 Anti-tumor necrosis factor-alpha agents and uses thereof |
| 07/25/2013 | WO2012156219A9 Amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides comprising the same |
| 07/25/2013 | US20130190481 Human antibodies that bind mesothelin, and uses thereof |
| 07/25/2013 | US20130190357 Compositions and methods for assessing and treating a precursor lesion and/or esophageal cancer |
| 07/25/2013 | US20130190250 Polynucleotides Encoding Human Signal Peptide-Containing Proteins |
| 07/25/2013 | US20130189774 Humanized immunoglobulin loci |
| 07/25/2013 | US20130189737 Dipeptides to enhance yield and viability from cell cultures |
| 07/25/2013 | US20130189736 Antibody composition-producing cell |
| 07/25/2013 | US20130189712 T2r, a novel family of taste receptors |
| 07/25/2013 | US20130189710 Method And Assay Kit For Detection Of Toxicity Induced By Pyrrolizidine Alkaloids |
| 07/25/2013 | US20130189285 Antibodies against ramp3 |
| 07/25/2013 | US20130189284 Antibodies with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides |
| 07/25/2013 | US20130189283 Carrier immunoglobulins and uses thereof |
| 07/25/2013 | US20130189281 Antibodies that bind par-2 |
| 07/25/2013 | US20130189279 Binding Molecules Against Chikungunya Virus and Uses Thereof |
| 07/25/2013 | US20130189278 Antagonists of pcsk9 |
| 07/25/2013 | US20130189273 Eg-vegf nucleic acids and polypeptides and methods of use |
| 07/25/2013 | US20130189272 Monoclonal Antibodies That Specifically Block Biological Activity Of A Tumor Antigen |
| 07/25/2013 | US20130189271 Monoclonal antibodies against her2 |
| 07/25/2013 | US20130189269 Actriib binding agents and uses thereof |
| 07/25/2013 | US20130189267 Means and methods for treating or preventing brain tumors based on the nuclear receptor tailless (tix) |
| 07/25/2013 | US20130189266 Mzb1, a novel b cell factor, and uses thereof |
| 07/25/2013 | US20130189265 Modified parvovirus having enhanced anti-tumor efficacy |